A simplified method to screen for in-vivo performance of oral lipid formulations

Journal of Pharmacy and Pharmacology

Volumn 66, Issue 5, 2014, Pages 615-623

  Kilic, Murat ^a   Dressman, Jennifer ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

biorelevant media; drug precipitation; in vitro lipolysis; lipid formulations; poorly soluble drugs

Indexed keywords

CALCIUM; DANAZOL; DRUG CARRIER; LIPID; PANCREATIN;

ANIMAL; DIET RESTRICTION; DOG; DRUG DELIVERY SYSTEM; INTESTINE; LIPID METABOLISM; LIPOLYSIS; MEDICINAL CHEMISTRY; METABOLISM; ORAL DRUG ADMINISTRATION; PH; SWINE;

ADMINISTRATION, ORAL; ANIMALS; CALCIUM; CHEMISTRY, PHARMACEUTICAL; DANAZOL; DOGS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FASTING; HYDROGEN-ION CONCENTRATION; INTESTINES; LIPID METABOLISM; LIPIDS; LIPOLYSIS; PANCREATIN; SWINE;

EID: 84898803134     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12182     Document Type: Article

References (25)

1. Hauss DJ,. Oral lipid-based formulations. Adv Drug Deliv Rev 2007; 59: 667-676.
2. Pouton CW,. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci 2006; 29: 278-287.
3. Porter CJ, et al. Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv Drug Deliv Rev 2008; 60: 673-691.
4. Pouton CW,. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. Eur J Pharm Sci 2000; 11: 93-98.
5. Porter CJ, et al. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov 2007; 6: 231-248.
6. Humberstone AJ, Charman WN,. Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv Drug Deliv Rev 1997; 25: 103-128.
7. MacGregor KJ, et al. Influence of lipolysis on drug absorption from the gastro-intestinal tract. Adv Drug Deliv Rev 1997; 25: 33-46.
8. Cuine JF, et al. Increasing the proportional content of surfactant (Cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs. Pharm Res 2007; 24: 748-757.
9. Cuine JF, et al. Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self-emulsifying formulations to dogs. J Pharm Sci 2008; 97: 995-1012.
10. Zangenberg NH, et al. A dynamic in vitro lipolysis model. I. Controlling the rate of lipolysis by continuous addition of calcium. Eur J Pharm Sci 2001; 14: 115-122.
11. Sek L, et al. Characterisation and quantification of medium chain and long chain triglycerides and their in vitro digestion products, by HPTLC coupled with in situ densitometric analysis. J Pharm Biomed Anal 2001; 25: 651-661.
12. Fatouros DG, et al. Morphological observations on a lipid-based drug delivery system during in vitro digestion. Eur J Pharm Sci 2007; 31: 85-94.
13. Jantratid E, et al. Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update. Pharm Res 2008; 25: 1663-1676.
14. Glomme A, et al. Comparison of a miniaturized shake-flask solubility method with automated potentiometric acid/base titrations and calculated solubilities. J Pharm Sci 2005; 94: 1-16.
15. Schamp K,. Lipidartige Formulierungen Zur Verbesserung Der Bioverfuegbarkeit Schwer Loeslicher Arzneistoffe. Frankfurt: JW Goethe University, 2002.
16. Keller J, et al. Duodenal and ileal nutrient deliveries regulate human intestinal motor and pancreatic responses to a meal. Am J Physiol 1997; 272: 632-637.
17. Keller J, Layer P,. Human pancreatic exocrine response to nutrients in health and disease. Gut 2005; 54: 1-28.
18. Bozkurt T, et al. Effect of atropine on intestinal phase of pancreatic secretion in man. Digestion 1988; 41: 108-115.
19. Armand M, et al. Physicochemical characteristics of emulsions during fat digestion in human stomach and duodenum. Am J Physiol 1996; 271: 172-183.
20. Lykidis A, et al. Combined effect of a lecithin and a bile salt on pancreatic lipase activity. Comp Biochem Physiol B Biochem Mol Biol 1997; 116: 51-55.
21. Perez de la Cruz Moreno M, et al. Characterization of fasted-state human intestinal fluids collected from duodenum and jejunum. J Pharm Pharmacol 2006; 58: 1079-1089.
22. Patton JS, et al. The light microscopy of triglyceride digestion. Food Microstruct 1985; 4: 29-41.
23. Clarysse S, et al. Postprandial evolution in composition and characteristics of human duodenal fluids in different nutritional states. J Pharm Sci 2009; 98: 1177-1192.
24. Vertzoni M, et al. Luminal lipid phases after administration of a triglyceride solution of danazol in the fed state and their contribution to the flux of danazol across Caco-2 cell monolayers. Mol Pharm 2012; 9: 1189-1198.
25. Schiller C, et al. Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging. Aliment Pharmacol Ther 2005; 22: 971-979.